6/17/2025
6/17/2025
Clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias with special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia,…
6/17/2025
Dr. Loughran's current research includes: current research includes: • R01 grant from the NIH’s National Cancer Institute to identify and characterize the LGL leukemia virus and understand how it might cause leukemia; •…
6/17/2025
Dr. Lum’s primary focus is enhancing the patient’s immune system to make it a better cancer-killing machine. Cancer immunotherapy works by utilizing a patient’s T cells, which are already programmed…
7/2/2026
6/17/2025
Clinical trials in hematologic malignancies including leukemias and lymphomas, with special interest in determining optimal combinations and timing of targeted agents in B-cell leukemias and lymphomas.
6/17/2025
Our tumor targeting strategy is based on arming activated T cells with low concentrations of bispecific antibodies to bridge the effector T cells with targets, resulting in tumor cell lysis,…
6/17/2025
Reduced intensity conditioning use, pre-transplant co-morbidity assessment.
